Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Contact
Online Exclusives
Biosimilars Excellence Forum
Blogs
Expert Insights
Latest News
Mantle Cell Lymphoma Excellence Forum
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
Colorectal Cancer
Featured
Videos
HRQoL Low Among Young Adult Colorectal Cancer Survivors
Kimberly Miller, PhD, MPH, discusses results from a study exploring HRQoL in colorectal cancer survivors who were diagnosed before age 50.
Podcast
NCCN Guideline Adherence Improves Survival Outcomes in Anal Cancer
Priyanka Kumar, MD, discusses a recent study which analyzed adherence to the NCCN treatment guidelines for anal…
Conference Coverage
Tumor Mutation Burden Unlikely Biomarker for Checkpoint Inhibitor Response in CRC
Results from a real-world study show tumor mutation burden is unlikely indicative of checkpoint inhibitor response for…
News
Doublet Therapy Unlikely Cost-Effective for Metastatic BRAF Variant Colorectal Cancer
While the use of doublet therapy for treating patients with metastatic BRAF variant colorectal cancer is associated…
Videos
DPYD Genotyping Cost-Effective Screening Strategy Prior to Adjuvant Chemotherapy in Colon Cancer
Gabriel Brooks, MD, MPH, discusses results from a study evaluating the cost-effectiveness of DPYD genotyping to screen…
News
Doublet Therapy Unlikely Cost-Effective for Metastatic BRAF Variant Colorectal Cancer
Practice-Changing Clinical Trials in Metastatic Colorectal Cancer
Cost-Effectiveness of FIT vs Colonoscopy for Colorectal Cancer Screening
Screen Average-Risk Adults Ages 50 to 75 for Colorectal Cancer: ACP
Guideline Updates
NCCN Updates Clinical Practice Guideline for Colorectal Cancer
Videos
HRQoL Low Among Young Adult Colorectal Cancer Survivors
Podcast
NCCN Guideline Adherence Improves Survival Outcomes in Anal Cancer
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top